Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Feng-Ming Spring Kong"'
Autor:
Haiyan Zeng, Dirk K.M. De Ruysscher, Xiao Hu, Danyang Zheng, Li Yang, Umberto Ricardi, Feng-Ming Spring Kong, Lizza E.L. Hendriks
Publikováno v:
Journal of the National Cancer Center, Vol 2, Iss 2, Pp 113-125 (2022)
Several guidelines including radiotherapy recommendations exist worldwide for the treatment of small cell lung cancer (SCLC). To evaluate the differences in radiotherapy recommendations we conducted a systematic review. PubMed and the sites of medica
Externí odkaz:
https://doaj.org/article/da46e2f5f73c4e8abedd0f07c401bddd
Autor:
Chi Leung Chiang, Francis Ann Shing Lee, Kenneth Sik Kwan Chan, Venus Wan Yan Lee, Keith Wan Hang Chiu, Ryan Lok Man Ho, John Ka Shun Fong, Natalie Sean Man Wong, Winnie Wing Ling Yip, Cynthia Sin Yu Yeung, Vince Wing Hang Lau, Kwan Man, Feng-Ming Spring Kong, Albert Chi Yan Chan
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Introduction While combination of stereotactic body radiotherapy (SBRT) and immunotherapy are promising, their efficacy and safety have not been compared with SBRT-alone in patients with unresectable HCC. Methods This retrospective study included 100
Externí odkaz:
https://doaj.org/article/c266e0fee9234f0cbe75792a502ab469
Autor:
Dongcheng Liu, Hongguang Liu, Jiadi Gan, Shinuan Zeng, Fuhua Zhong, Bin Zhang, Zhe Zhang, Siyu Zhang, Lu Jiang, Guangsuo Wang, Yixin Chen, Feng-Ming Spring Kong, Wenfeng Fang, Lingwei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Non-small cell lung carcinoma (NSCLC) patients who initially received tyrosine kinase inhibitor (TKI) therapy often acquired resistance via multiple complex mechanisms. The amplification of FGF3/4/19/CCND1 on chromosome 11q13 was found in many cancer
Externí odkaz:
https://doaj.org/article/51ac84481c534c0c9e2c578496ce2004
Autor:
Fang Chen, Jian-Yue Jin, Timothy S.K. Hui, Haiman Jing, Hong Zhang, Yaqing Nong, Ying Han, Weili Wang, Lingyu Ma, Fan Yi, Qingqing Chen, Yongsheng Zhang, Pingfu Fu, Li Yang, Zhiyuan Xu, Feng-Ming Spring Kong
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLymphopenia is a known significant factor for treatment outcome in cancer patients, with underlying risk factor poorly understood in breast cancer. We hypothesize that the effective dose to the circulating immune cells (EDIC) which was rela
Externí odkaz:
https://doaj.org/article/bee00cf8583e4e60963c5d85b39033d1
Autor:
Fang Chen, Timothy S.K. Hui, Lingyu Ma, Yaqing Nong, Ying Han, Haiman Jing, Eric K.W. Lee, Zhiyuan Xu, Pingfu Fu, Amy Tien Yee Chang, Victor Hsue, Feng-Ming Spring Kong
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeApplication of hypofractionated radiotherapy (HFRT) is growing in patients with breast cancer (BC). This study aimed to explore a real-world practice of HFRT in early and locally advanced BC.MethodsPatients with invasive BC between 2015 and 20
Externí odkaz:
https://doaj.org/article/2dc5a81a8aed46d0a70f69a9ff42a886
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Externí odkaz:
https://doaj.org/article/f257664e8cdd484abb5eda29a6c55e4e
Autor:
Hao Yu, Ka-On Lam, Huanmei Wu, Michael Green, Weili Wang, Jian-Yue Jin, Chen Hu, Shruti Jolly, Yang Wang, Feng-Ming Spring Kong
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundRadiation-induced lung fibrosis (RILF) is an important late toxicity in patients with non-small-cell lung cancer (NSCLC) after radiotherapy (RT). Clinically significant RILF can impact quality of life and/or cause non-cancer related death.
Externí odkaz:
https://doaj.org/article/781b7e358a0644f7b77d4c5e9dd46089
Autor:
Yinnan Meng, Wei Luo, Wei Wang, Chao Zhou, Suna Zhou, Xingni Tang, Liqiao Hou, Feng-Ming Spring Kong, Haihua Yang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
PurposeAlthough intensity-modulated radiotherapy (IMRT) is now a preferred option for conventionally fractionated RT in lung cancer, the commonly used cutoff values of the dosimetric constraints are still mainly derived from the data using three-dime
Externí odkaz:
https://doaj.org/article/9f326c32e5b2493d8b41488ce4698736
Autor:
Brittany Z. Dashevsky, Chenpeng Zhang, Li Yan, Cindy Yuan, Lingyun Xiong, Yongmei Liu, Haiyan Liu, Feng-Ming Spring Kong, Yonglin Pu
Publikováno v:
European Journal of Hybrid Imaging, Vol 1, Iss 1, Pp 1-10 (2017)
Abstract Purpose TNM Stage 3B encompasses a wide range of primary tumor and nodal metastatic tumor burden. This study aimed to evaluate the prognostic value of quantitative FDG PET/CT parameters in patients with newly diagnosed Stage 3B Non-Small Cel
Externí odkaz:
https://doaj.org/article/4ec4906916044ee58fd2ffab13f428e7
Autor:
Jing Zhao, Yingfeng Xia, Joseph Kaminski, Zhonglin Hao, Frank Mott, Jeff Campbell, Ramses Sadek, Feng-Ming Spring Kong
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157455 (2016)
Treatment related death (TRD) is the worst adverse event in chemotherapy and radiotherapy for patients with cancer, the reports for TRDs were sporadically. We aimed to study TRDs in non-small cell lung cancer (NSCLC) patients treated with concurrent
Externí odkaz:
https://doaj.org/article/ac545b6ac64445ca99069ee28aa9b609